Association of obstructive sleep apnea with cognitive impairment and small vessel disease

Obstructive sleep apnea (OSA) has been associated with mild cognitive impairment (MCI). Cerebral small vessel disease (CSVD) is considered a neuroimaging marker for MCI. Objective: To evaluate the association between OSA, cognitive impairment and vessel disease. Methods: We prospectively recruited i...

Full description

Autores:
Otero, Liliana
Riveros Rivera, Alain
Uriza Carrasco, Luis Felipe
Matallana, Diana
Hidalgo Martínez, Patricia
Reyes, Pablo
Tipo de recurso:
Article of journal
Fecha de publicación:
2019
Institución:
Pontificia Universidad Javeriana
Repositorio:
Repositorio Universidad Javeriana
Idioma:
eng
OAI Identifier:
oai:repository.javeriana.edu.co:10554/52998
Acceso en línea:
https://openres.ersjournals.com/content/5/suppl_3/P119
http://hdl.handle.net/10554/52998
https://doi.org/10.1183/23120541.sleepandbreathing-2019.P119
Palabra clave:
Rights
License
Atribución-NoComercial 4.0 Internacional
Description
Summary:Obstructive sleep apnea (OSA) has been associated with mild cognitive impairment (MCI). Cerebral small vessel disease (CSVD) is considered a neuroimaging marker for MCI. Objective: To evaluate the association between OSA, cognitive impairment and vessel disease. Methods: We prospectively recruited individuals diagnosed through polysomnography with severe OSA (S; n=21), moderate OSA (M; n=18), and healthy individuals (H; n=9). Behavioral Data included screening tests with Montreal Cognitive assessment test (MOCA), Ineco Frontal Screening Test (IFS), Language by verbal fluency, Verbal Memory by selective memory verbal test, Attention executive by paced auditory serial addition test (PASAT), selective attention by digit symbol of WAIS, and executive functions like inhibition by Stroop test and Hayling test. Lesions in white matter was established through Magnetic resonance imaging (MRI). Results: The frequency of CSVD was higher in patients with OSA ((H=22%; M=38%; S=38%). Splitting the participants according to SVD, we found significant differences in cognitive parameters such LTMs (nonSVD=29; SVD=38, p=0.05) and PASAT (nonSVD=6.7; SVD=10.6 p=0.03). Data as mean ± SEM. LTMs scores varied according to the group (H=40±6; M=38±3 and S=28±3) with significant differences H vs S (p=0.04) and M vs S (p=0.02). Remaining cognitive measurements, between those groups were not different. Conclusions: These preliminary findings suggest that mild cognitive impairment in patients with OSA is associated with CSVD